A new cell screening method that can be used to identify potential anti-influenza drugs has been developed by the Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and its national and international collaborators. The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine and prove the efficacy of a previously known drug saliphenylhalamide. The ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment